VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
FDMT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
FDMT4D Molecular Therapeutics, Inc.
$12.25$640M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksFDMTQuarterly Balance Sheet

4D Molecular Therapeutics, Inc. (FDMT) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

4D Molecular Therapeutics, Inc. (FDMT) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

FDMT Balance Sheet

Quarterly statement

FDMT Balance Sheet

4D Molecular Therapeutics, Inc. (FDMT) balance sheet — 9-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Total Current Assets382.96M405.36M413.13M312.38M303.29M332.57M434.93M510.76M552.63M535.59M296.59M328.24M317.78M207.04M220.51M232.48M246.52M243.05M256.28M165.73M
Cash & Short-Term Investments361.33M390.89M402.65M305.06M293.23M321.44M424.88M501.89M541.95M525.91M288.23M319.66M310.34M200.45M213.55M227.72M241.09M236.15M247.78M161.68M
Cash Only70.37M72.49M60.24M48.55M77.16M133.53M149.34M187.54M189.06M275.59M249.11M275.68M236.31M78.57M52.35M108.3M113.48M75.97M153M90.99M
Short-Term Investments290.96M318.4M342.41M256.51M216.07M187.91M275.54M314.35M352.88M250.32M39.12M43.99M74.03M121.89M161.2M119.42M127.6M160.18M94.78M70.69M
Accounts Receivable4.61M0000000000000700K00047K791K
Days Sales Outstanding110.98-------------51.64---41967.65
Inventory00000000000000000000
Days Inventory Outstanding--------------------
Other Current Assets17.01M14.47M10.48M7.31M10.06M11.13M10.05M8.87M10.69M9.68M8.36M8.58M7.43M6.59M6.26M00003.27M
Total Non-Current Assets109.66M107.54M153.58M111.61M170.35M183.16M125.45M93.27M67.48M94.3M43.3M33.37M34.73M36.98M41.34M47.69M56.41M81.88M97.21M74.89M
Property, Plant & Equipment28.93M30.94M33.01M35.06M37.15M39.12M40.61M41.63M29.45M30.58M31.66M32.69M33.65M34.32M35.35M35.51M34.92M32.64M28.95M8.79M
Fixed Asset Turnover0.13x0.10x2.50x0.00x0.00x0.00x0.00x0.00x0.00x0.00x-0.00x0.61x0.01x0.01x0.04x0.01x0.00x0.04x0.00x0.19x
Goodwill00000000000000000000
Intangible Assets00000000000000000000
Long-Term Investments69.3M66.74M111.38M67.17M123.81M137M80.58M48.78M35.72M62.94M10.95M001.41M4.91M11.12M20.53M48.36M67.65M65.49M
Other Non-Current Assets11.44M9.86M9.19M9.38M9.39M7.04M4.26M2.86M2.32M771K684K682K1.08M1.26M1.08M1.05M963K875K602K602K
Total Assets492.62M512.9M566.71M423.98M473.64M515.73M560.38M604.03M620.12M629.88M339.89M361.61M352.5M244.02M261.85M280.16M302.94M324.93M353.49M240.62M
Asset Turnover0.01x0.01x0.17x0.00x0.00x0.00x0.00x0.00x0.00x0.00x-0.00x0.06x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.01x
Asset Growth %4.01%-0.55%1.13%-29.81%-23.62%-18.12%64.87%67.04%75.92%158.13%29.81%29.07%16.36%-24.9%-25.92%16.44%18.83%20.29%22.6%145.05%
Total Current Liabilities47.67M43.4M43.98M37.11M34.68M26.9M29.15M29.46M19.4M16.4M18.95M18.16M13.75M11.28M15.73M13.56M14.33M12.09M16.34M11.37M
Accounts Payable12.52M14.69M11.16M6.86M8.7M4.15M4.39M2.92M3.43M4.22M3.52M4.71M3.49M2.41M3.32M1.48M3.32M2.68M4.76M3.71M
Days Payables Outstanding592.74566.08418.6915.1612.199.44188.497.610.9212.6214.5415.0611.3811.5110.2711.6513.3617.2922.2516.48
Short-Term Debt000000003.2M000002.65M00000
Deferred Revenue (Current)360K360K360K360K1.07M866K257K35K00273K130K576K778K884K2.21M2.26M2.11M2.6M1.73M
Other Current Liabilities29.42M00000007.28M03.87M0003.18M00000
Current Ratio8.03x9.34x9.39x8.42x8.75x12.36x14.92x17.33x28.48x32.65x15.65x18.07x23.11x18.36x14.02x17.14x17.20x20.10x15.69x14.57x
Quick Ratio8.03x9.34x9.39x8.42x8.75x12.36x14.92x17.33x28.48x32.65x15.65x18.07x23.11x18.36x14.02x17.14x17.20x20.10x15.69x14.57x
Cash Conversion Cycle--------------------
Total Non-Current Liabilities37.28M17.66M17.06M17.89M18.07M19.11M20.63M21.61M12.37M12.92M13.11M13.52M13.61M14.14M14.78M15.16M16.09M16.78M18.04M5.11M
Long-Term Debt19.59M0000000000000000000
Capital Lease Obligations14.26M15.05M15.82M16.57M17.36M18.17M18.97M19.74M10.46M11M11.52M12.03M12.53M13.01M13.47M13.92M14.4M14.78M15.22M0
Deferred Tax Liabilities00000000000000000000
Other Non-Current Liabilities485K491K496K489K495K499K603K592K596K600K617K389K236K248K233K236K234K236K334K2.1M
Total Liabilities84.96M61.07M61.05M55M52.75M46.01M49.78M51.08M31.78M29.32M32.06M31.68M27.36M25.41M30.51M28.72M30.42M28.87M34.38M16.48M
Total Debt39.22M20.54M21.41M22.26M23.08M23.85M24.61M24.83M13.66M14.17M14.67M15.16M15.63M15.68M16.12M16.55M17M16.82M16.45M0
Net Debt-31.16M-51.95M-38.83M-26.29M-54.08M-109.67M-124.73M-162.71M-175.41M-261.42M-234.44M-260.52M-220.68M-62.89M-36.23M-91.75M-96.49M-59.15M-136.55M-90.99M
Debt / Equity0.10x0.05x0.04x0.06x0.05x0.05x0.05x0.04x0.02x0.02x0.05x0.05x0.05x0.07x0.07x0.07x0.06x0.06x0.05x-
Debt / EBITDA--1.28x-----------------
Net Debt / EBITDA---2.33x-----------------
Interest Coverage-------------------79.37x-
Total Equity407.66M451.84M505.66M368.98M420.89M469.72M510.61M552.95M588.34M600.56M307.83M329.93M325.14M218.61M231.34M251.44M272.52M296.06M319.11M224.13M
Equity Growth %-3.14%-3.81%-0.97%-33.27%-28.46%-21.79%65.87%67.59%80.95%174.72%33.07%31.22%19.31%-26.16%-27.5%12.18%13.24%22.12%24.46%219.48%
Book Value per Share5.806.648.736.577.538.439.479.9510.6412.197.877.818.486.687.127.768.439.1911.818.29
Total Shareholders' Equity407.66M451.84M505.66M368.98M420.89M469.72M510.61M552.95M588.34M600.56M307.83M329.93M325.14M218.61M231.34M251.44M272.52M296.06M319.11M224.13M
Common Stock6K5K6K5K5K5K5K5K5K5K4K4K4K3K3K3K3K3K3K3K
Retained Earnings-858M-785.06M-716.3M-735.7M-678.83M-624.17M-576.2M-526.52M-482.68M-447.73M-415.33M-383.04M-372.79M-343.17M-314.49M-287.11M-261.42M-233.33M-207M-181.91M
Treasury Stock00000000000000000000
Accumulated OCI-446K-180K727K671K337K332K229K1.08M-293K-109K16K534K345K-270K-1.2M-1.85M-1.83M-1.42M-423K-195K
Minority Interest00000000000000000000